Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Approves Tarceva For Pancreatic Cancer

Nov 02 2005

• By Kathleen Michael

Related Content

Oncology Sales Drive Strong Quarter For Genentech

Oct 11 2005

Tarceva Pancreatic Cancer Survival Benefit Is Small But Clinically Meaningful, Committee Says

Sep 13 2005

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window